U.S. Capital Markets Stock News

NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Will Greg Abel’s Delta Bet and Buffett’s Share Conversions Change Berkshire Hathaway's (BRK.A) Narrative

In recent days, Berkshire Hathaway has seen new CEO Greg Abel build a substantial stake in Delta Air Lines while Warren Buffett converted 8,000 Class A shares into 12 million Class B shares for donation to four family-linked foundations, as part of his plan to distribute all his Berkshire holdings by the end of 2034. Together, Abel’s move into airlines and Buffett’s accelerated philanthropy highlight a generational handover that is reshaping both Berkshire’s portfolio direction and its...
NYSE:SPG
NYSE:SPGRetail REITs

Does SPG’s Raised 2026 FFO Guidance Signal Durable Cash Flow Strength Or Heightened Execution Risk?

Simon Property Group recently updated investors that it is set to release its second-quarter results, alongside raising its full-year 2026 Real Estate FFO guidance after a period of consistent earnings outperformance versus analyst expectations. This combination of an upcoming results catalyst and higher full-year guidance sharpens attention on how reliably the REIT is translating operating trends into cash flow. We’ll now examine how Simon Property Group’s raised full-year Real Estate FFO...
NasdaqGS:SBUX
NasdaqGS:SBUXHospitality

Is Starbucks (SBUX) Fairly Valued On Its Dividend Update And Turnaround Story?

Starbucks (SBUX) recently affirmed a quarterly cash dividend of $0.62 per share, payable on August 28, 2026. This is a key income detail for investors tracking the stock’s mix of returns. See our latest analysis for Starbucks. The latest session saw Starbucks share price slip 1.09% to US$106.17, even as the wider market moved higher. The stock still shows a 30 day share price return of 3.04% and a year to date share price return of 26.44%, alongside a 1 year total shareholder return of 17.83%...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab Stock And 2 Penny Stocks With Stronger Balance Sheets

Penny stocks often look risky at first glance, but the Financially Fit Penny Stocks screener aims to spotlight companies that pair low share prices with a focus on financial health. With inflation, energy costs and interest rate expectations moving markets worldwide, many investors are looking for ideas that keep risk in check while still offering exposure to early stage growth stories. This article highlights 3 candidates from the Financially Fit Penny Stocks screener, helping you narrow a...
NasdaqGM:NMIH
NasdaqGM:NMIHDiversified Financial

NMI Holdings (NMIH) Gets Analyst Backing, Is It Still 9% Undervalued?

JP Morgan analyst Richard Shane recently reiterated an Overweight rating on NMI Holdings (NMIH) and raised his price target, while recent insider selling adds a contrasting signal that investors may want to weigh carefully. See our latest analysis for NMI Holdings. At a share price of $41.91, NMI Holdings has seen a 13.12% 1 month share price return and a 12.39% 1 year total shareholder return, indicating momentum that has developed gradually rather than in a single spike. If this mix of...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

JD.com (JD) Could Be 8% Overvalued After Fresh Earnings Upgrades

JD.com (JD) has drawn fresh attention after being added to the Zacks Rank #1 (Strong Buy) List, following a 10.5% uplift in next year earnings estimates over the past two months. See our latest analysis for JD.com. JD.com’s share price has recently rebounded, with an 8.87% 7 day share price return. However, it remains under pressure over longer periods, as shown by a 1 year total shareholder return decline of 6.85% and a 5 year total shareholder return decline of 55.57%. This suggests that...
NYSE:WELL
NYSE:WELLHealth Care REITs

How Investors May Respond To Welltower (WELL) Strong Senior Housing Metrics And Options-Focused Income Strategy

In recent weeks, Welltower Inc., the largest senior housing REIT, reported strong growth in net operating income and funds from operations, while attracting attention for an income-focused options strategy tied to its role in the “silver economy.” Media coverage highlighting robust operating metrics, together with commentary about solid institutional support on pullbacks, underscores how professional investors view Welltower as a key landlord in senior housing despite concerns that many...
NasdaqGS:FSLR
NasdaqGS:FSLRSemiconductor

First Solar Stock And 2 US Clean Energy Names Backed by Domestic Supply Chains

Google’s move to source power from the Steel River Energy Center, the largest solar project in the US, is a fresh reminder that huge buyers are still hungry for clean electricity and long-term contracts. At the same time, tighter rules around tax credits and Chinese imports are pushing more of the value chain onshore. For investors, that combination puts a spotlight on companies with real exposure to US-based solar and storage projects, domestic manufacturing, and grid-scale solutions. This...
NYSE:RYAN
NYSE:RYANInsurance

Is Ryan Specialty (RYAN) Using Renewables Push to Sharpen Its Specialty Insurance Edge?

Ryan Specialty Underwriting Managers has appointed Jeff Smith as CEO of the newly formed Ryan Specialty Renewables, created by unifying and rebranding its PERse North America, PERse International, and Albus renewable energy underwriting units into a single global platform expected to be completed in Q3 2026. This consolidation signals a clear push to build a more cohesive, specialized presence in renewable and energy transition insurance, potentially enhancing Ryan Specialty’s product depth...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Does Cognizant’s Expanded Frontier AI Talent Pool Reshape the Bull Case for Cognizant Technology Solutions (CTSH)?

Cognizant Technology Solutions has recently expanded its AI efforts by scaling a Frontier-certified workforce, launching the Neuro AI Trust governance platform, deepening its Google Cloud Gemini collaboration, partnering with Domyn on sovereign AI in EMEA, and applying GPT-5.5 with Trusted Access for Cyber to bolster enterprise cyber defense. Together, these moves position Cognizant as an AI integrator focused on secure, governed, and industry-specific deployments, aiming to bridge what it...
NYSE:NUE
NYSE:NUEMetals and Mining

Caterpillar Stock And 2 Industrial Names Exposed To US Tariff Shifts

Tariffs are back in the spotlight, and this time the stakes are high for companies exposed to US trade policy swings. With the Supreme Court striking down major Trump-era tariffs and triggering about $81 billion in refunds, while fresh tariffs of 10 to 12.5% are being prepared, some stocks may see fresh openings while others face new pressure. This article looks at 3 stocks directly exposed to those tariff shifts, highlighting 2 that could see clearer opportunities and 1 that may carry higher...
NasdaqGS:FROG
NasdaqGS:FROGSoftware

Is JFrog (FROG) Using Canadian Federal Access To Sharpen Its Public‑Sector Expansion Strategy?

In recent days, JFrog Ltd. announced that its Software Supply Chain Platform is now available for procurement through the Government of Canada’s Software Licensing Supply Arrangement Catalogue via reseller Data Centre Intelligence, giving federal departments and Crown corporations a standardized way to purchase the technology. This move opens a new public-sector procurement channel in Canada, underscoring how rising demand for software supply chain security and AI governance is influencing...
NYSE:APTV
NYSE:APTVAuto Components

Aptiv (APTV) Expands Kyndryl Tie Up, Is The Stock Still Undervalued?

Kyndryl’s new collaboration with Aptiv (APTV) highlights how the company is using its Wind River software portfolio to support mission-critical systems and edge AI in complex customer environments. See our latest analysis for Aptiv. Despite the Kyndryl alliance spotlighting Aptiv’s software capabilities, the stock has faced selling pressure, with the 30-day share price return down 14.68% and the year-to-date share price return down 25.98%, while the 1-year total shareholder return is down...
NasdaqGS:VICR
NasdaqGS:VICRElectrical

AppLovin Stock And 2 AI Infrastructure Shares With Strong Earnings Growth

With inflation, energy prices and interest rate expectations all pulling markets in different directions, many investors are looking for companies that aim to grow earnings while still keeping their balance sheets under control. That is exactly what the Healthy high growth potential screener focuses on. It highlights stocks where analysts expect strong earnings growth over the next 3 years and financial positions that meet clear quality criteria. In this article, you will see 3 of the best...
NYSE:AIZ
NYSE:AIZInsurance

5% Below Fair Value? Assurant (AIZ) After The Analyst Upgrade

Analyst upgrade puts fresh focus on Assurant stock A recent upgrade of Assurant (AIZ) to a Zacks Rank #2, with an accompanying A grade for Value, has put the stock back on investors’ radar as earnings estimates shift higher. The change in rating is tied to analysts’ revised earnings expectations, while valuation metrics such as price to book and price to sales are being highlighted as potential strengths relative to the broader insurance peer group. See our latest analysis for...
NYSE:CTVA
NYSE:CTVAChemicals

Corteva (CTVA) Could Be 6% Below Fair Value On Arevo Soybean Seed Deal

Corteva (CTVA) stock is drawing attention after the company partnered with Arevo AB to integrate Arginex Soy, an arginine-based seed treatment, into its soybean seed treatment portfolio for improved crop nutrition and sustainability. See our latest analysis for Corteva. Corteva shares, which closed at US$84.91, have cooled slightly in the last week but still show firm momentum, with a 30 day share price return of 11.52% and a 5 year total shareholder return of 114.79%. If this kind of product...
NYSE:CWEN
NYSE:CWENRenewable Energy

Clearway Energy (CWEN) Adjusts Insider Equity, Is The Undervalued Case Still Intact?

Insider equity adjustment gives Clearway investors a fresh data point Clearway Energy (CWEN) recently disclosed a small internal equity adjustment involving the forfeiture of 101 shares of Class C common stock, a routine governance event that still offers investors another reference point on ownership structure. The forfeited shares were previously granted under a long term equity incentive program and are now held directly by Clearway Energy Group LLC. Following this adjustment, affiliated...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

ADMA Biologics (ADMA) Puts Growth Narrative To The Test As Fair Value Stays In Focus

Adma Biologics (ADMA) drew fresh attention after its stock fell 1.21%, trailing broader indices, as investors looked ahead to an earnings release in which analysts expect higher earnings per share and revenue compared with last year. See our latest analysis for ADMA Biologics. At a share price of $8.87, ADMA Biologics has seen short term momentum soften, with the share price return down over the past week and quarter, while a very large 5 year total shareholder return shows how strong earlier...
NYSE:SITE
NYSE:SITETrade Distributors

SiteOne Landscape Supply (SITE) Stock Looks Cheap On Cash Flow While Earnings Look Pricey

SiteOne Landscape Supply stock has fallen 38.7% over the past five years, yet the current intrinsic value estimate using a Discounted Cash Flow (DCF) approach suggests the shares may still trade below that modelled value, while the broader valuation checks paint a less generous picture. Over five years, SiteOne Landscape Supply has declined 38.7%, which places extra focus on whether the current price reflects the company’s longer term cash flow potential. Future cash generation from its...
NYSE:DAL
NYSE:DALAirlines

Delta’s Higher Revenue but Lower Profit and Shelf Filing Could Be A Game Changer For Delta Air Lines (DAL)

In the second quarter of 2026, Delta Air Lines reported revenue of US$19,757 million, up from US$16,648 million a year earlier, while net income declined to US$1,604 million from US$2,130 million. Despite pressure from sharply higher fuel costs and lower earnings per share, Delta reaffirmed its full-year outlook and bolstered liquidity options by filing an omnibus shelf registration for multiple types of securities. Next, we’ll examine how Delta’s reaffirmed full-year outlook, despite record...
NasdaqGS:CEVA
NasdaqGS:CEVASemiconductor

Does Landmark AI Licensing Deal With Major Platform Player Change The Bull Case For CEVA (CEVA)?

Ceva, Inc. recently announced a landmark AI licensing agreement with a major U.S. software and AI platform company, centered on its NeuPro-M architecture for custom silicon in next-generation intelligent computing devices. This deal broadens Ceva’s reach beyond traditional chipmakers to influential software platform customers seeking tightly integrated hardware-software AI solutions at the edge. We’ll now examine how this push into custom AI silicon for software platform companies could...
NasdaqGM:AAOI
NasdaqGM:AAOICommunications

Can Applied Optoelectronics (AAOI) Still Look Fairly Valued After AI Demand?

Applied Optoelectronics stock has delivered a very large 5 year return, yet its current valuation picture is mixed, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to a roughly fair price while other checks suggest the stock is not a clear bargain overall. Over the past 5 years, Applied Optoelectronics has returned about 15.9x, which puts extra focus on whether the current share price is still supported by its fundamentals. Investor expectations around...
NYSE:WRB
NYSE:WRBInsurance

W. R. Berkley (WRB) Names Carolina Casualty Chief As Valuation Stays In Focus

Why the latest leadership move at W. R. Berkley matters for shareholders W. R. Berkley (WRB) has appointed Paul J. Stock as president of Carolina Casualty, a move that puts an experienced transportation focused insurance executive in charge of a key operating unit. See our latest analysis for W. R. Berkley. Despite a 2.5% decline in the 1 day share price return to around $71.98, W. R. Berkley has seen its 30 day share price return of 5.4% and 90 day share price return of 8.9% align with a 1...
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

Is Jazz Pharmaceuticals (JAZZ) Still Undervalued On Its Oncology And Neuroscience Growth Story?

Recent Performance Context for Jazz Pharmaceuticals Stock Jazz Pharmaceuticals (JAZZ) has drawn investor attention after a period of strong longer term returns, with the stock showing gains over the past year and past 3 years, alongside positive revenue and net income growth. See our latest analysis for Jazz Pharmaceuticals. At a share price of $238.05, Jazz Pharmaceuticals has had a 90 day share price return of 19.43% and a year to date share price return of 37.48%. The 1 year total...